Advertisement

How to Induce Arrhythmias with Aminophylline?

  • Habib Rehman Khan
Chapter

Abstract

Aminophylline, a methylxanthine, is a 2:1 combination between theophylline and ethylenediamine. The 2:1 ratio improves the solubility of the product. Compared to theophylline, aminophylline is a less potent nonselective adenosine receptor antagonist and phosphodiesterase inhibitor. The effects on the sinus node are reduction in the corrected sinus node recovery time and sinoatrial conduction time. The effect on the atrial tissue is reduction in the atrial refractory period. The effect on the AV node was decrease in the Wenckebach point and AH time. The effect on the His-Purkinje system is reduction in the HV conduction time. There was no change in the ventricular refractory period.

References

  1. 1.
    Abu-Laban RB, et al. Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial. Lancet. 2006;367(9522):1577–84.CrossRefGoogle Scholar
  2. 2.
    Hayward E, Showler L, Soar J. Aminophylline in bradyasystolic cardiac arrest. Emerg Med J. 2007;24(8):582–3.CrossRefGoogle Scholar
  3. 3.
    Hurley KF, Magee K, Green R. Aminophylline for bradyasystolic cardiac arrest in adults. Cochrane Database Syst Rev. 2013;(8):CD006781.Google Scholar
  4. 4.
    Stirt JA, Sullivan SF. Aminophylline. Anesth Analg. 1981;60(8):587–602.CrossRefGoogle Scholar
  5. 5.
    Ostapiuk M, et al. [Effect of aminophylline on electrophysiological characteristics of the accessory pathway in patients with Wolff-Parkinson-White syndrome]. Kardiol Pol. 1988;31(3):173–9.Google Scholar
  6. 6.
    Lerman BB, et al. Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism. J Clin Invest. 1988;82(6):2127–35.CrossRefGoogle Scholar
  7. 7.
    Prokocimer PG, et al. Epinephrine arrhythmogenicity is enhanced by acute, but not chronic, aminophylline administration during halothane anesthesia in dogs. Anesthesiology. 1986;65(1):13–8.CrossRefGoogle Scholar
  8. 8.
    Stirt JA, et al. Aminophylline pharmacokinetics and cardiorespiratory effects during halothane anesthesia in experimental animals. Anesth Analg. 1980;59(3):186–91.CrossRefGoogle Scholar
  9. 9.
    Molenda W, et al. [Effect of aminophylline on the heart conduction system in patients with paroxysmal nodal tachycardia]. Kardiol Pol. 1988;31(2):84–90.Google Scholar
  10. 10.
    Molenda W, et al. [Effect of aminophylline on the ventricular part of the heart conduction system]. Pol Arch Med Wewn. 1988;79(5):256–62.Google Scholar
  11. 11.
    Molenda W, et al. Effect of aminophylline on the heart conduction system in patients with concealed accessory atrioventricular node bypass. Pol Tyg Lek. 1987;42(10):287–90.Google Scholar
  12. 12.
    Lerman BB, Wesley RC, Belardinelli L. Electrophysiologic effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia. Role of endogenous adenosine. Circulation. 1989;80(6):1536–43.CrossRefGoogle Scholar
  13. 13.
    Malcolm AD, Garratt CJ, Camm AJ. The therapeutic and diagnostic cardiac electrophysiological uses of adenosine. Cardiovasc Drugs Ther. 1993;7(1):139–47.CrossRefGoogle Scholar
  14. 14.
    Montenero AS, et al. [Electrophysiologic and hemodynamic effects of intravenous aminophylline in humans]. Cardiologia. 1987;32(9):1005–7.Google Scholar
  15. 15.
    Nicholson DP, Chick TW. A re-evaluation of parenteral aminophylline. Am Rev Respir Dis. 1973;108(2):241–7.PubMedGoogle Scholar
  16. 16.
    Eiriksson CE Jr, Writer SL, Vestal RE. Theophylline-induced alterations in cardiac electrophysiology in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987;135(2):322–6.PubMedGoogle Scholar
  17. 17.
    Sessler CN, Cohen MD. Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study. Chest. 1990;98(3):672–8.CrossRefGoogle Scholar
  18. 18.
    Ichikawa K, et al. A case of life-threatening supraventricular tachycardia storm associated with theophylline toxicity. J Cardiol Cases. 2017;15(4):125–8.CrossRefGoogle Scholar
  19. 19.
    Levine JH, Michael JR, Guarnieri T. Multifocal atrial tachycardia: a toxic effect of theophylline. Lancet. 1985;1(8419):12–4.CrossRefGoogle Scholar
  20. 20.
    Belhassen B, et al. Autonomic modulation of aminophylline influence on the electrophysiological effects of adenosine and adenosine triphosphate in the canine heart. Cardiovasc Res. 1987;21(2):151–60.CrossRefGoogle Scholar
  21. 21.
    Komadina KH, et al. Electrophysiologic study of the effects of aminophylline and metaproterenol on canine myocardium. Chest. 1992;101(1):232–8.CrossRefGoogle Scholar
  22. 22.
    Redmond JM, et al. Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation. J Heart Lung Transplant. 1993;12(1 Pt 1):133–8; discussion 138–9.PubMedGoogle Scholar
  23. 23.
    Heinz G. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol. 1997;29(2):470–1.CrossRefGoogle Scholar
  24. 24.
    Bertolet BD, et al. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol. 1996;28(2):396–9.CrossRefGoogle Scholar
  25. 25.
    Paloucek FP, Rodvold KA. Evaluation of theophylline overdoses and toxicities. Ann Emerg Med. 1988;17(2):135–44.CrossRefGoogle Scholar
  26. 26.
    Laaban JP, et al. Cardiac arrhythmias during the combined use of intravenous aminophylline and terbutaline in status asthmaticus. Chest. 1988;94(3):496–502.CrossRefGoogle Scholar
  27. 27.
    Marrouche NF, et al. Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. J Am Coll Cardiol. 2002;39(6):1046–54.CrossRefGoogle Scholar
  28. 28.
    Telichowski C, et al. [Effect of aminophylline on the occurrence of reciprocal tachycardia in patients with Wolff-Parkinson-White syndrome]. Wiad Lek. 1987;40(19):1353–7.Google Scholar
  29. 29.
    Varriale P, Ramaprasad S. Aminophylline induced atrial fibrillation. Pacing Clin Electrophysiol. 1993;16(10):1953–5.CrossRefGoogle Scholar
  30. 30.
    Aliot EM, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6(6):886–933.CrossRefGoogle Scholar
  31. 31.
    Lerman BB. Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects. Circulation. 1993;87(2):382–90.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Habib Rehman Khan
    • 1
    • 2
  1. 1.Royal Brompton and Harefield, NHS TrustLondonUK
  2. 2.National Heart and Lung Institute, Imperial CollegeLondonUK

Personalised recommendations